GlassScriptPhysician profile
Ahmed Shahata
NPI 1871060608
$8,071.58
in general payments reported to CMS, 2019-2025
23 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $153 · 2021: $209 · 2022: $598 · 2023: $385 · 2024: $5,556 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,440 · Travel and Lodging: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,439.79 |
| Travel and Lodging | $1,068.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,989.34 | 2024-2025 | |
| Abbvie INC. | $438.50 | 2020-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Organon LLC | $249.67 | 2021-2024 | |
| Amgen INC. | $187.93 | 2019-2022 | |
| Myovant Sciences INC. | $181.78 | 2022 | |
| Conmed Corporation | $151.33 | 2025 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $148.99 | 2023-2025 | |
| Sage Therapeutics, LLC | $115.87 | 2022-2024 | |
| Exeltis, USA INC. | $97.97 | 2022-2025 | Slynd, Solosec |
| Sumitomo Pharma America, INC. | $94.36 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $91.02 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $85.42 | 2023-2024 | Veozah |
| Ethicon US, LLC | $35.46 | 2024 | Stratafix |
| Agile Therapeutics, INC. | $34.83 | 2021 | |
| Meditrina | $26.13 | 2023-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.68 | 2024 | Ligasure |
| Merck Sharp & Dohme LLC | $23.87 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $22.50 | 2023 | |
| Kci USA, INC. | $15.94 | 2021 | |
| Daiichi Sankyo INC. | $15.91 | 2021 | |
| Roche Diagnostics Corporation | $13.94 | 2019 | |
| Coopersurgical, INC. | $12.91 | 2019 | |
| Olympus America INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Shahata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.